Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05870579
Title [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries POL | FRA | ESP | DEU

Facility Status City State Zip Country Details
Novartis Investigative Site RECRUITING Bordeaux 33076 France Details
Novartis Investigative Site RECRUITING Clermont-Ferrand 63011 France Details
Novartis Investigative Site RECRUITING Saint Herblain 44805 France Details
Novartis Investigative Site RECRUITING Essen 45147 Germany Details
Novartis Investigative Site RECRUITING Koeln 50937 Germany Details
Novartis Investigative Site RECRUITING Muenchen 80377 Germany Details
Novartis Investigative Site RECRUITING Gliwice 44 101 Poland Details
Novartis Investigative Site RECRUITING Porto 4200-072 Portugal Details
Novartis Investigative Site RECRUITING Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site RECRUITING Hospitalet de LLobregat Catalunya 08907 Spain Details
Novartis Investigative Site RECRUITING Madrid 28034 Spain Details
Novartis Investigative Site RECRUITING Madrid 28040 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field